ABSTRACT
Designed ankyrin repeat proteins (DARPins) are valuable tools in both biochemistry and medicine. Herein we describe a rapid, simple method for the dual modification of DARPins by introduction of cysteine mutations at specific positions that results in a vast difference in their thiol nucleophilicity, allowing for clean sequential modification.
Subject(s)
Ankyrins/metabolism , Ankyrins/chemistry , Ankyrins/genetics , Circular Dichroism , Cysteine/metabolism , Humans , Mutagenesis, Site-Directed , Protein Binding , Protein Engineering , Receptor, ErbB-2/chemistry , Receptor, ErbB-2/metabolism , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Recombinant Proteins/geneticsABSTRACT
Reversible protein biotinylation is readily affected via conjugation with a bromomaleimide-based reagent followed by reductive cleavage. The intermediate biotinylated protein constructs are stable at physiological temperature and pH 8.0. Quantitative reversibility is elegantly delivered under mild conditions of using a stoichiometric amount of a bis-thiol, thus providing an approach that will be of general interest in chemical biology and proteomics.
Subject(s)
Affinity Labels/chemistry , Biotin/chemistry , Maleimides/chemistry , Streptavidin/chemistry , Hydrogen-Ion Concentration , Hydrolysis , Models, Molecular , Protein Structure, Tertiary , TemperatureABSTRACT
Local protein microenvironment is used to control the outcome of reaction between cysteine residues and 2,5-dibromohexanediamide. The differential reactivity is exploited to introduce two orthogonal reactive handles onto the surface of a double cysteine mutant of superfolder green fluorescent protein in a regioselective manner. Subsequent elaboration with commonly used thiol and alkyne containing reagents affects site-selective protein dual labelling.
ABSTRACT
Bromomaleimides react rapidly and selectively with cysteine to afford thiomaleimides which can be cleaved with a phosphine to regenerate the cysteine or treated with a base to afford dehydroalanine.